微气泡/超音波造影剂市场规模、份额和成长分析（按产品类型、应用、最终用户、给药途径和地区划分）—产业预测（2026-2033 年）

全球微气泡/超音波造影剂市场规模预计在 2024 年达到 26.2 亿美元，从 2025 年的 27.4 亿美元增长到 2033 年的 39.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.6%。

在医学影像领域，造影对于提高体液和组织结构的可见度至关重要，尤其是在利用微气泡进行超音波检查时。这些微气泡在放射学和心臟病学中用作血池造影剂，具有多种应用，包括基因治疗、药物递送、分子成像和干细胞递送。透过配体分子修饰，微泡可以针对疾病特异性标记物，从而实现对血管状态的精确监测、发炎成像以及肿瘤血管的评估。静脉注射的微气泡模拟循环中的红血球，并对超音波脉衝做出反应，导致其大小发生动态变化，并在灌注组织中产生强烈的迴声。这项技术利用气体和软组织迴声强度的差异，显着增强了超音波诊断和影像对比。

全球微气泡/超音波造影剂市场驱动因素

全球微气泡/超音波造影剂市场成长的主要驱动力是人们对标靶治疗日益增长的兴趣以及对精确监测血管内皮生物标记状态的需求。超音波技术的创新、对精准诊断解决方案不断增长的需求，以及这些造影剂相对于传统诊断方法的显着优势，预计将推动市场成长。此外，慢性病盛行率的上升也是促进该市场扩张的关键因素，因为医疗保健机构正在寻求利用先进影像技术更有效地观察和诊断健康状况。

限制全球微气泡/超音波造影剂市场的因素

全球微气泡/超音波造影剂市场的主要挑战之一是微气泡寿命有限。这一固有特性严重限制了其在各种医疗应用中的有效性和效用。由于微气泡在生物环境中会迅速消散，其短暂性限制了其在长时间成像程序中的应用，阻碍了市场成长。因此，这项限制影响了造影剂的整体应用，因为医疗专业人员正在寻求更持久的替代方案，以便在更长的时间内提供可靠的诊断结果。因此，解决微气泡保质期短的问题仍是市场发展的关键挑战。

全球微气泡/超音波造影市场趋势

全球微气泡/超音波造影剂市场正呈现微气泡创新应用超越传统影像应用的显着趋势。微气泡泡作为分子影像标靶化剂的新兴作用，反映了人们日益认识到其在提高诊断准确性方面的潜力。透过使用能够特异性结合疾病相关生物标记的配体分子对微泡进行功能化修饰，临床医生现在可以更有效地监测各种病理状况，包括肿瘤血管、发炎和缺血再灌流伤害。随着医疗机构越来越多地采用先进的诊断工具来改善患者预后并促进个人化医疗，这种向分子影像应用的转变预计将推动市场成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球微气泡/超音波造影剂市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 定义
• 欧普蒂森
• 声波视图
• 勒梅森
• 其他的

全球微气泡/超音波造影剂市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 心臟病学
• 肿瘤学
• 妇科
• 其他的

全球微气泡/超音波造影剂市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 诊断影像中心
• 专科诊所
• 研究和学术机构

全球微气泡/超音波造影剂市场规模（按给药途径和复合年增长率划分）（2026-2033 年）

• 静脉注射
• 血管内给药
• 动脉内给药
• 其他的

全球微气泡/超音波造影剂市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

  主要企业简介

  • Bracco Imaging SpA（义大利）
  • GE医疗（美国）
  • Lantheus Holdings, Inc.（美国）
  • 富士软片视觉声学公司（加拿大）
  • 西门子医疗股份公司（德国）
  • 佳能医疗系统株式会社（日本）
  • 三星麦迪逊有限公司（韩国）
  • 迈瑞生物医疗电子有限公司（中国）
  • 飞利浦医疗保健（荷兰）
  • Advanced Microbubbles Laboratories BV（荷兰）
  • Targeson公司（美国）
  • VisualSonics（加拿大）
  • NanoMedical Diagnostics, Inc.（美国）
  • 美敦力股份公司（德国）
  • Insightec有限公司（以色列）
  • SuperSonic Imagine SA（法国）
  • 远距医疗超音波系统（立陶宛）

结论与建议

Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 2.62 Billion in 2024 and is poised to grow from USD 2.74 Billion in 2025 to USD 3.93 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

In the medical imaging sector, contrast agents are essential for enhancing fluid or structural visibility, particularly via microbubbles in ultrasound applications. Serving as blood pool agents in radiology and cardiology, these microbubbles have diverse uses, including gene therapy, drug delivery, molecular imaging, and stem cell delivery. They can be tailored with ligand molecules to target disease-specific markers, enabling precise monitoring of vascular conditions, inflammation imaging, and tumor vasculature assessment. Administered intravenously, microbubbles mimic red blood cells in circulation and respond to ultrasound pulses, creating dynamic variations in size and generating strong echoes from perfused tissue. This technology capitalizes on the differences in echogenicity between gases and soft tissues, significantly enhancing ultrasound diagnosis and imaging contrast.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbubbles/Ultrasound Contrast Agents Market Segments Analysis

Global Microbubbles/Ultrasound Contrast Agents Market is segmented by Product Type, Application Area, End-user, Route of Administration and region. Based on Product Type, the market is segmented into Definity, Optison, Sonovue, Lumason and Others. Based on Application Area, the market is segmented into Cardiology, Oncology, Gynecology and Others. Based on End-user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Specialty Clinics and Research and Academic Institutes. Based on Route of Administration, the market is segmented into Intravenous, Intravascular, Intra-arterial and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microbubbles/Ultrasound Contrast Agents Market

The Global Microbubbles/Ultrasound Contrast Agents market is propelled by the rising interest in targeted therapies and the necessity to accurately monitor biomarker conditions within the vascular endothelium. The market is expected to experience growth driven by innovations in ultrasound technology, a heightened demand for precise diagnostic solutions, and the distinct advantages these agents offer compared to conventional diagnostic methods. Furthermore, the increasing prevalence of chronic diseases is also a significant factor contributing to this market's expansion, as healthcare providers seek more effective ways to visualize and diagnose health conditions using advanced imaging techniques.

Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market

One significant challenge facing the Global Microbubbles/Ultrasound Contrast Agents market is the limited lifespan of microbubbles. This inherent property poses a considerable limitation, hindering their effectiveness and utility in various medical applications. As microbubbles dissipate quickly in biological environments, their transient nature can restrict their use in prolonged imaging procedures, ultimately impeding the growth of the market. Consequently, this limitation affects the overall adoption of these contrast agents, as healthcare providers seek more durable alternatives that can provide reliable diagnostic results over extended periods. Thus, addressing the short duration of microbubble efficacy remains a crucial hurdle for market development.

Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market

The Global Microbubbles/Ultrasound Contrast Agents market is witnessing a significant trend towards the innovative utilization of microbubbles beyond traditional imaging applications. Their emerging role as targeted agents for molecular imaging reflects a growing recognition of their potential in enhancing diagnostic precision. By functionalizing microbubbles with ligand molecules that specifically bind to disease-related biomarkers, clinicians can now monitor various conditions such as tumor vasculature, inflammation, and ischemia-reperfusion injuries more effectively. This shift towards molecular imaging applications is expected to drive market growth, as healthcare providers increasingly adopt advanced diagnostic tools that improve patient outcomes and facilitate personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Microbubbles/Ultrasound Contrast Agents Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Definity
• Optison
• Sonovue
• Lumason
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Cardiology
• Oncology
• Gynecology
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Research and Academic Institutes

Global Microbubbles/Ultrasound Contrast Agents Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Intravenous
• Intravascular
• Intra-arterial
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size & CAGR (2026-2033)

• North America (Product Type, Application Area, End-user, Route of Administration)
  • US
  • Canada
• Europe (Product Type, Application Area, End-user, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application Area, End-user, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application Area, End-user, Route of Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application Area, End-user, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM VisualSonics, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Microbubbles Laboratories B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Targeson, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VisualSonics (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoMedical Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtron AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SuperSonic Imagine S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Telemed Ultrasound Systems (Lithuania)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations